Bipolar I Disorder
128
17
21
85
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Published Results
42 trials with published results (33%)
Research Maturity
85 completed trials (66% of total)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
3.9%
5 terminated out of 128 trials
94.4%
+7.9% vs benchmark
45%
57 trials in Phase 3/4
49%
42 of 85 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 85 completed trials
Clinical Trials (128)
Long-term Safety Extension Study of OLZ/SAM in Pediatric Subjects
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)
Pharmacokinetics, Safety, Tolerability and Efficacy of a Subcutaneous Long-Acting Injection of Cariprazine (Cariprazine Depot) in Subjects Eligible for Treatment With Oral Cariprazine
SYNCED - SYNChronized Eating in Bipolar Depression Study
A Study of Elpipodect (MK-8189) in Participants With Bipolar I Disorder (MK-8189-020)
A Study to Investigate Lithium Brain/Plasma Pharmacokinetics and Safety of an AL001 Oral Capsule Compared to a Marketed Immediate-release Lithium Carbonate Capsule in Subjects With Bipolar I Disorder
Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.
A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Mania
Low Field Magnetic Stimulation: Imaging Biomarkers in Geriatric Bipolar Depression
A Study of Spoken Language in Mania
Early Psychosis Intervention - Spreading Evidence-based Treatment
Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder
An Open-label Study of Azetukalner in Bipolar I or II Depression (X-CEED-OLE)
LHC-CIDI-5 in Hong Kong
Ketamine for Treatment-Resistant Bipolar Disorder
Maintenance Ketamine Infusions for Treatment-Resistant Bipolar Depression
Observational Study of Oral Cariprazine Capsules to Assess Change in Disease Activity in Adult Participants With Bipolar I Disorder